Company news

Venus Medtech (Hangzhou), Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026

October 6, 2026

Poll results of the extraordinary general meeting

September 30, 2026

2026 Interim report

September 23, 2026

Proxy form for use at the egm

September 14, 2026

Notice of extraordinary general meeting

September 14, 2026

Proposed subscription of new shares and new convertible bonds under specific mandate and (2) notice of extraordinary general meeting

September 14, 2026

Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement

October 25, 2025

Court Sides with Cardiovalve in Edwards patent spat

August 5, 2025

Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations

April 21, 2025

Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve

January 25, 2022

Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement

December 7, 2021

Decks